BASF Plant Science is a subsidiary of BASF in which all plant biotechnology activities are consolidated. The GmbH was founded in 1998 and employs approximately 700 people at 6 different locations worldwide. The headquarters of BASF Plant Science is located in Research Triangle Park (North Carolina, USA). Plant Science has research sites in the US, Canada and Europe. At these locations the company is mainly developing genetically modified seeds.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company's strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.

Shenzhen Xinrui Gene Technology Co., Ltd., established on 2021-11-12, Business scope includes general business items:Development of Human Gene Diagnosis and Therapy Technology;Artificial intelligence basic resources and technology platform;Research and development of bio-based materials technology;New material technology research and development;Biochemical product technology research and development;Pharmaceutical special equipment manufacturing;Pharmaceutical special equipment sales;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services;internet data service;software development;Financing Advisory Services;Engage in industrial investment with own funds,Investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:none

Shuimu Future (Beijing) Technology Co., Ltd., established on 2017-12-07, The business scope includes the sale of third-class medical devices;Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Basic software service;Application software service;software development;software consulting;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Conference Services;Undertake exhibition and display activities;Organize cultural and artistic exchange activities(Does not include commercial performances);Sell ​​self-developed products,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Equipment,medical instrumentsIIkind;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.

Evonik Operations GmbH manufactures specialty chemicals. The company was founded on August 23, 2000 and is headquartered in Weatherford, TX.

Shenzhen Comen Medical Instruments Co. Ltd. is a Chinese private company that manufactures and distributes medical equipment.

Fujitsu Ltd. engages in the provision of information technology (IT) services. It operates through the following segments: Technology Solutions, Ubiquitous Solutions, and Device Solutions. The Technology Solutions segment provides system integration, consulting, outsourcing, cloud, network, and system support services. It also offers system and network products such as servers, storage systems, software, network management systems, and mobile base stations. The Ubiquitous Solutions segment covers personal computers (PCs). The Device Solutions segment includes electronic components such as semiconductor packages and batteries. The company was founded on June 20, 1935 and is headquartered in Tokyo, Japan.